Muireann Quigley

Professor of Law, Medicine, & Technology University of Birmingham @bhamlaw. Also tweeting @EverydayCyborgs.

[Muireann Quigley @profmq]

New paper out by myself, @LauraJDowney, @zaina_mahmoud94, & @JeanMcHale2. Setting out where we are with medical devices regulation in the UK, how we got here, & where we might be going.

[@LawTechHum @LawTechHum]

In latest issue @profmq @LauraJDowney @zaina_mahmoud94 and Jean McHale analyse the complex situation regarding the regulation of #MedicalDevices in the UK #innovation #PatientSafety @EverydayCyborgs
🔗https://t.co/aMZfmeDUVL

[Muireann Quigley @profmq]

Later today, presenting some work on psychedelics. Based on a chapter I have written with Dr Matt Hayler (English Lit @ UoB)

[CHLSP @CHLSPBIRMINGHAM]

Our next @CHLSPBIRMINGHAM event is a joint seminar with @bhamlaw - a Hybrid Seminar Wednesday 16th Oct- 13:00- on Zoom / in person . Delighted that @profmq will be presenting on "A Psychedelic Research Agenda for Europe? The Quest for Therapeutic and Legal Legitimacy.” 1/2

[PatentsInHumans @PatentsInHumans]

@PatentsInHumans Prof Aisling McMahon & Dr Opeyemi Kolawole article just out #MedicalLawReview on 'Biobank Donation in search of public benefits & Potential impact of IPRs over access to health technologies developed: A focus on bioethical implications' https://t.co/pmMbX9Lhq8

[Psychedelic Alpha @Psyched_Alpha]

Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran Singh

https://t.co/nJvPc8lsDC

[Sam Halliday @DrSamHalliday]

Really excited to see this published today in @MedLawInt - my latest article considering the construction of the best interests of women with a SMI in the obstetric context and the untapped potential of advance decisions.

[Muireann Quigley @profmq]

@gerardcummins Congratulations Gerard!

[Psychedelic Alpha @Psyched_Alpha]

ICER Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy Deems Clinical Evidence “Insufficient”

https://t.co/iPaz1aC44v

[Psychedelic Alpha @Psyched_Alpha]

MindMed becomes the fourth organisation to receive such FDA Breakthrough Therapy Designation for a psychedelic drug candidate.

Previously, MAPS, Compass Pathways and Usona Institute received the designation, for MDMA and psilocybin (x2), respectively.

[Psychedelic Alpha @Psyched_Alpha]

FDA Hands MindMed's LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase 3 Program Plans

Our coverage:
https://t.co/w3Nod0DcW7

[Psychedelic Alpha @Psyched_Alpha]

Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison Centre Calls

https://t.co/CDapi5JkAW

[CHLSP @CHLSPBIRMINGHAM]

The next @CHLSPBIRMINGHAM Zoom seminar will be held on Thursday 7th March at 13:00. @sabrinakgermain & Emily Allbon @CityLawSchool & Mara Malagodi @Warwick_Law are giving the paper “Reproductive Rights as Socio-Economic Rights in Nepal” All very welcome!

[Psychedelic Alpha @Psyched_Alpha]

Colorado’s Draft Natural Medicine Rules: A High-Level Overview

The first draft rules for CO's regulated psychedelics market were revealed on Feb 16th.

The folks at Vicente LLP have parsed through the 39-page draft rules to provide a concise overview.

https://t.co/FFQ9GjgsXC

[Faculti @FacultiNet]

Emma Cave @profEmmaCave @DurhamLawSchool @durham_uni discusses how the sufficiency of young adults’ autonomy is judged in light of biological, social and psychological evidence that #adolescence can continue into the mid 20s https://t.co/7CeJ9pLM1a #law #medicallaw

[Christoph Bublitz @JCBublitz]

A brief thread about a new paper by me on neurotech & human rights. Right at the time when #Neuralink reports its first in-human brain-computer interface implant (which is btw not the first brain implant, but a new device implanted through a new method)../
https://t.co/ulPsKkJ5Lo

[Muireann Quigley @profmq]

@fdelond @bhamlaw Well deserved, congratulations!

[Medical Law International @MedLawInt]

We are looking for two new associate editors! Pls RT and get in touch if you have any questions ✨

[Psychedelic Alpha @Psyched_Alpha]

Bullseye Chart: The Psychedelic Drug Development Pipeline

@MichaelHaichin and @NoahJSmith98 have produced the latest iteration of our psychedelic drug dev. bullseye chart.

Access and download the full-size chart here:
https://t.co/iOMggjhgCw

[Susi Geiger @complexmarkets]

Good news - today is NOT the last day to submit an abstract to this unmissable event! There's another couple of weeks to do so!
@ilagalasso @SErikainen @PickersgillM

[Psychedelic Alpha @Psyched_Alpha]

Interview: Compass Pathways $CMPS CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape

https://t.co/aTFqTC1g7u

[Muireann Quigley @profmq]

So much yes to all of this. Relevant not just for privacy law scholarship, but all of it!

[Lilian Edwards @lilianedwards]

This is probably the most useful piece of privacy law Scholarship I ever read. Recommended to junior (or perhaps senior) colleagues..
https://t.co/oOLJRHTlal